imkindly

Alot of people with Hepatitis C Virus seem to be under the impression that they can't be organ donors.
They can.
There's a shortage of organ donors right now (that's why everyday 15 people on the organ transplant waiting list Die waiting.)
According to most OPO's....the number one reason that people don't sign an organ donor card is that they think their body is "too sick" and "wouldn't be used anyway".
Organ donors save lives.
People with Hepatitis C can be organ donors.

And for those of you who are doubters....

Here's a good article about Hepatitis C Donors:

Volume 65, Number 7, April 1998

LONG-TERM OUTCOME OF PATIENTS TRANSPLANTED WITH LIVERS FROM HEPATITIS C-POSITIVE DONORS

Giuliano Testa, Robert M. Goldstein, George Netto, Osman Abbasoglu, Barbara K. Brooks, Marlon F. Levy, Bo S. Husberg, Thomas A. Gonwa, and Goran B. Klintmalm

Transplantation Services, Baylor University Medical Center, Dallas, Texas 75246

Background: The use of hepatitis C serology-positive donors has become an option in patients affected by hepatitis C (Hep C) end-stage liver disease. Previous studies with less than 1 year of follow-up have suggested that there is no difference in early patient and graft survival. The aim of our review is to confirm with a longer follow-up (a minimum of 1 year) that the use of these organs is safe and that patient and graft survival are comparable to those of patients with Hep C who received Hep C-negative grafts.

Methods: Between 1985 and 1995, 213 patients were transplanted with a diagnosis of Hep C. Seventy-six patients were excluded from the study, 47 for insufficient follow-up and 29 because the diagnosis of recurrence was not certain. Twenty-two patients received Hep C+ donor grafts and 115 patients received Hep C- donor grafts. These two groups were evaluated to assess the rate and severity of recurrence by serial biopsies and to assess patient and graft survival.

Results: Recurrent Hep C was documented by biopsy in 12 of 22 patients who received Hep C+ donor grafts. Of these 12 patients, 9 had mild chronic hepatitis, 2 had fibrosis, and 1 had cirrhosis. Ten of the 22 patients had normal biopsies. Of the patients who received Hep C- grafts, 48 of 115 had recurrent disease. Of these 48 patients, 23 had mild chronic hepatitis, 15 had fibrosis, and 10 had cirrhosis. Sixty-seven of 115 had normal biopsies. The recurrence rate was 54.55% in the Hep C+ donor grafts and 41.74% in the Hep C- donor grafts (P=NS). Patient and graft survival at 4 years after transplant were 83.9% and 71.9% in the Hep C+ donor grafts and 79.1% and 76.2% in the Hep C- donor grafts, respectively (P=NS).

Conclusions: Our study suggests that Hep C+ donors can be used with excellent long-term results and that the progression of the recurrent disease does not seem to be affected by the pre-existence of the Hep C virus in the donor.

© 2001 Lippincott Williams & Wilkins [url="http://www.transplantjournal.com/"]http://www.transplantjournal.com/[/url]
Volume 65, Number 7, April 1998